Pulmonary capillary recruitment in exercise and pulmonary hypertension
- PMID: 29545320
- DOI: 10.1183/13993003.00260-2018
Pulmonary capillary recruitment in exercise and pulmonary hypertension
Conflict of interest statement
Conflict of interest: H. Olschewski reports grants from Bayer, Unither Pharmaceuticals, Actelion Pharmaceuticals Ltd, Roche, Boehringer Ingelheim and Pfizer Inc.; personal fees from Gilead Sciences Inc., Encysive Pharmaceuticals Ltd and Nebu-Tec; and personal fees and non-financial support from Bayer, Unither Pharmaceuticals, Actelion Pharmaceuticals Ltd, Pfizer Inc., Eli Lilly, Novartis, Astra Zeneca, Boehringer Ingelheim, Chiesi, Menarini, MSD and GSK, all outside the submitted work. Conflict of interest: G. Kovacs reports personal fees and non-financial support from Actelion, Bayer, GSK, MSD, Pfizer, AOP, Boehringer Ingelheim, Novartis and Chiesi, outside the submitted work.
Comment on
-
An official European Respiratory Society statement: pulmonary haemodynamics during exercise.Eur Respir J. 2017 Nov 22;50(5):1700578. doi: 10.1183/13993003.00578-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29167297
-
Pulmonary capillary recruitment in exercise and pulmonary hypertension.Eur Respir J. 2018 Mar 15;51(3):1702559. doi: 10.1183/13993003.02559-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29545319 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical